Clinical Trials Browser

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Mycobacterium Infections, Neoplasm Recurrence, Local, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT01171482 2017-04-26

Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma

Phase 2 Terminated

5 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT00271011 2015-12-03

A Study of Mitomycin C, Irinotecan, and Cetuximab

Phase 2 Terminated

13 enrolled 5 charts

Gastrointestinal

Colorectal Neoplasms

NCT00974818 2015-11-20

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Phase 3 Terminated

50 enrolled 7 charts

Genitourinary

Urinary Bladder Neoplasms

NCT00002993 2013-07-09

Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus

Phase 2 Terminated

30 enrolled

Sarcoma

NCT00033644 2013-04-11

Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus

Phase 2 Terminated

Sarcoma

NCT00042887 2012-09-24

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer

Phase 3 Terminated

58 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT00068744 2012-09-24

Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer

Phase 2/3 Terminated

88 enrolled

Gastrointestinal

Anus Neoplasms

NCT00967291 2012-02-01

PACT-11

Phase 2 Terminated

21 enrolled

Gastrointestinal

Pancreatic Neoplasms

Clinical Trials

TIM

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

ATLAS

Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer

BOND

Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck

RITE-USA

276

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites

EMBARC-RF

Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma

A Study of Mitomycin C, Irinotecan, and Cetuximab

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus

Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer

Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer

PACT-11